NathanGossaiMD

Pediatric Hematology & Oncology • Minneapolis, MN

Pediatric Hematologic Oncology

Physician

Join to view full profile

Dr. Gossai is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Gossai's full profile

Already have an account?

Office
2525 Chicago Ave
Minneapolis, MN 55404
Phone+1 612-813-6100

Fax+1 651-220-5147

Summary

Dr. Nathan Gossai is a pediatric hematologist/oncologist in Minneapolis, MN and is affiliated with multiple hospitals in the area, including Children's Hospitals and Clinics of Minnesota and University of Minnesota Medical Center, Fairview. He received his medical degree from Georgetown University School of Medicine and has been in practice 6 years. He specializes in pediatric hematologic oncology.

Education & Training

University of MinnesotaFellowship, Pediatric Hematology/Oncology, 2013 - 2016
University of MinnesotaResidency, Pediatrics, 2010 - 2013
Georgetown University School of MedicineClass of 2010

Certifications & Licensure

MN State Medical License 2013 - 2025
WI State Medical License 2017 - 2025
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

Award Session Presentation SIOP, 2019

Clinical Trials

Matched Targeted Therapy For High-Risk Leukemias and Myelodysplastic Syndrome Start of enrollment: 2016 Aug 17
Active, not recruiting
Not Applicable
PO Ixazomib in Combination With Chemotherapy for Childhood Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Start of enrollment: 2019 Feb 12
Active, not recruiting
Phase 1, Phase 2
LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis Start of enrollment: 2016 Nov 02
Recruiting
Phase 2, Phase 3
Roles: Contact

Publications & Presentations

PubMed

Acute megakaryoblastic leukemia associated with Sotos syndrome: A case report and review of evolving genetic associations.
Maria Landherr, Megan Hilgers, Dinel Pond, Lane H Miller, Nathan Gossai
Pediatric Blood & Cancer. 2024-11-01
Novel therapies for pediatric acute lymphoblastic leukemia.
Zachary Graff, Michael J Burke, Nathan Gossai
Current Opinion in Pediatrics. 2024-02-01
The role of nelarabine in the treatment of T-cell acute lymphoblastic leukemia/lymphoma: challenges, opportunities, and future directions.
Lane H Miller, Kim L Maxa, Stuart S Winter, Nathan P Gossai
Expert Review of Anticancer Therapy. 2023-12-08

Abstracts/Posters

Phase 1 Study of Decitabine and Vorinostat Followed By Fludarabine, Cytarabine and G-CSF (FLAG) in Children, Adolescents and Young Adults with Relapsed/Refractory AML:...
Nathan Gossai, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

Matched Targeted Therapy for Pediatric Patients with Relapsed, Refractory or High-Risk Leukemias: A Report from the LEAP ConsortiumClinically Relevant Abstract
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018